Braveheart Bio (BRVE) IPO deck
Braveheart Bio is a biotechnology company focused on the production and development of oral small-molecule therapies for serious cardiovascular diseases.
Braveheart Bio is a biotechnology company focused on the production and development of oral small-molecule therapies for serious cardiovascular diseases.
%20IPO%20deck){kind=link}